Beyond the tumor stage prognostic factors are useful for decision - ma
king in patients with prostatic carcinoma. In multivariate studies the
tumor volume has been ranked highest as a prognostic factor, followed
by DNS ploidy. Both are thought to be independent factors. Prognostic
factors based on the primary tumor are of little value in advanced ca
ncer. Symptoms (e.g. pain) or performance scores are related to progno
sis, but in two multivariate studies was the ranking different. Furthe
rmore, subjective prognosticators are adversely influenced by the regr
ession-dilution bias. PSA is a recognized time-dependent factor, but i
s also useful as an objective predictor of prognosis. Before a paramet
er is used for prognostic purposes, ist is necessary to determine whet
her it has true prognostic value or merely indicates that patients wit
h a short survival time are more likely to have an unfavorable prognos
ticator than those with a longer survival time.